Thoracent

Thoracent is a medical device company based in Long Island, New York, founded in 2017. The company specializes in distributing innovative pulmonary and gastrointestinal (GI) medical devices in the U.S. market. Thoracent focuses on non-vascular stents, which are mesh tubes used to open passages in the lungs or GI tract that are constricted by malignant lesions, providing palliative relief to enhance patients' quality of life. The flagship product of Thoracent is the BONASTENT tracheobronchial stent, designed with a nitinol woven structure and an ultra-slim delivery system that allows for precise placement. Thoracent is also the exclusive U.S. distributor of the Y-Stent, a unique metal Y-shaped stent that addresses airway and esophageal obstructions. The company serves interventional pulmonologists, thoracic surgeons, and gastroenterologists, emphasizing quality manufacturing and customer support. Thoracent has been recognized on the Inc. 5000 list of fastest-growing private companies, highlighting its growth and influence in the medical device industry.

• Employees 16
• Founded 2017